CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN was reported 2531 times

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRIS TEAR 1 0.5000
1 KERATECTOMY 1 0.1667
2 CONTACT LENS THERAPY 1 0.1667
3 LIP LESION EXCISION 1 0.1429
4 LID MARGIN DISCHARGE 2 0.0741
5 HYPERAESTHESIA EYE 1 0.0667
6 SCLERAL HYPERAEMIA 45 0.0661
7 EYE ABRASION 3 0.0566
8 FAECAL ELASTASE CONCENTRATION ABNORMAL 1 0.0556
9 INSTILLATION SITE COMPLICATION 1 0.0476
10 KIDNEY ABLATION 1 0.0455
11 CORNEAL IMPLANT 1 0.0435
12 INSTILLATION SITE HYPERSENSITIVITY 1 0.0435
13 ARTIFICIAL HEART IMPLANT 1 0.0417
14 DONOR LEUKOCYTE INFUSION 1 0.0385
15 BRAIN STENT INSERTION 1 0.0357
16 GLAUCOMA DRAINAGE DEVICE PLACEMENT 2 0.0345
17 KERATOMILEUSIS 7 0.0272
18 LENS EXTRACTION 1 0.0263
19 IRIS DISCOLOURATION 1 0.0217
20 INSTILLATION SITE FOREIGN BODY SENSATION 3 0.0207
21 BENIGN NEOPLASM OF EYE 1 0.0200
22 CORNEAL OPERATION 2 0.0194
23 INFUSION SITE EXFOLIATION 1 0.0192
24 CAROTID ARTERIAL EMBOLUS 1 0.0189
25 CONJUNCTIVAL BLEB 1 0.0185
26 FOREIGN BODY SENSATION IN EYES 112 0.0176
27 CONTAMINATED PRODUCT ADMINISTERED 1 0.0164
28 REACTION TO PRESERVATIVES 13 0.0160
29 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
30 INSTILLATION SITE PAIN 38 0.0153
31 EYELID SENSORY DISORDER 3 0.0152
32 INSTILLATION SITE DISCOMFORT 2 0.0149
33 EYE COMPLICATION ASSOCIATED WITH DEVICE 4 0.0149
34 OCULAR ROSACEA 3 0.0148
35 CORNEAL THICKENING 1 0.0147
36 PRODUCT CONTAINER ISSUE 116 0.0135
37 CARDIAC STEATOSIS 1 0.0135
38 EYELID PAIN 27 0.0133
39 PERIORBITAL PAIN 11 0.0130
40 ABNORMAL SENSATION IN EYE 54 0.0125
41 LIMBAL STEM CELL DEFICIENCY 1 0.0122
42 INTRAOCULAR LENS IMPLANT 6 0.0121
43 FOREIGN BODY IN EYE 11 0.0115
44 EYELASH CHANGES 2 0.0113
45 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
46 RETINAL OPERATION 3 0.0108
47 PRODUCT INFORMATION CONTENT COMPLAINT 3 0.0108
48 LACRIMATION DECREASED 5 0.0105
49 EYE DISCHARGE 109 0.0105
50 PRODUCT ODOUR ABNORMAL 107 0.0102
51 EYELID EXFOLIATION 8 0.0101
52 EYELID IRRITATION 24 0.0096
53 CATHETER SITE INJURY 2 0.0094
54 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
55 FEMALE GENITAL OPERATION 1 0.0090
56 THERMAL BURNS OF EYE 2 0.0088
57 CONJUNCTIVITIS BACTERIAL 3 0.0088
58 EYE IRRITATION 505 0.0088
59 BILIRUBIN URINE PRESENT 1 0.0084
60 BLOOD GASTRIN INCREASED 1 0.0078
61 CORNEAL TRANSPLANT 6 0.0077
62 CORNEAL EROSION 4 0.0074
63 EYE OPERATION 34 0.0074
64 CARCINOID TUMOUR OF THE STOMACH 1 0.0071
65 CYSTIC LUNG DISEASE 1 0.0070
66 EPENDYMOMA 1 0.0069
67 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
68 OCULAR DISCOMFORT 77 0.0069
69 MEDICAL DEVICE SITE DISCHARGE 1 0.0065
70 BLOOD INSULIN DECREASED 1 0.0065
71 ERYTHEMA OF EYELID 34 0.0063
72 EYELIDS PRURITUS 19 0.0061
73 EYE DEGENERATIVE DISORDER 1 0.0060
74 EYE PAIN 331 0.0059
75 PTERYGIUM 2 0.0058
76 INSTILLATION SITE SWELLING 1 0.0057
77 INSTILLATION SITE ERYTHEMA 3 0.0057
78 GLASSY EYES 4 0.0056
79 EYELID MARGIN CRUSTING 16 0.0055
80 SUPERFICIAL INJURY OF EYE 6 0.0055
81 BORDERLINE GLAUCOMA 1 0.0054
82 DEAFNESS PERMANENT 1 0.0051
83 HYPOAESTHESIA EYE 3 0.0051
84 EYE LASER SURGERY 3 0.0051
85 MICROGRAPHIC SKIN SURGERY 1 0.0047
86 EXPOSURE TO FUNGUS 1 0.0047
87 BREAST HAEMATOMA 1 0.0044
88 OCULAR HYPERAEMIA 200 0.0042
89 CORNEAL NEOVASCULARISATION 1 0.0040
90 ASTHENOPIA 22 0.0040
91 BURNING FEET SYNDROME 1 0.0040
92 BLEPHARAL PIGMENTATION 2 0.0040
93 CHRONIC DISEASE 1 0.0039
94 DRAIN PLACEMENT 1 0.0039
95 BREAST DISORDER FEMALE 1 0.0039
96 EYELID CYST 1 0.0039
97 INJURY CORNEAL 2 0.0038
98 PRODUCT DROPPER ISSUE 3 0.0038
99 NEOVASCULARISATION 1 0.0038
100 CHOLANGITIS INFECTIVE 1 0.0038
101 DEPOSIT EYE 1 0.0037
102 EYELID OPERATION 1 0.0037
103 POOR QUALITY PRODUCT ADMINISTERED 39 0.0037
104 CUTIS LAXA 1 0.0037
105 EPIRETINAL MEMBRANE 1 0.0036
106 CHEMICAL BURNS OF EYE 1 0.0036
107 EYE INFECTION BACTERIAL 2 0.0036
108 DRY EYE 177 0.0035
109 LENS DISORDER 1 0.0035
110 ENDOCRINE OPHTHALMOPATHY 3 0.0035
111 LIVER OPERATION 1 0.0032
112 ALLERGY TO VACCINE 1 0.0032
113 HORDEOLUM 14 0.0032
114 FEAR OF EATING 1 0.0032
115 MULTIPLE USE OF SINGLE-USE PRODUCT 18 0.0032
116 CORNEAL INFILTRATES 1 0.0032
117 BREAST CELLULITIS 1 0.0032
118 MEDICATION RESIDUE PRESENT 15 0.0031
119 EYE PRURITUS 104 0.0031
120 PRODUCT CONTAMINATION 11 0.0031
121 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
122 BREAST HAEMORRHAGE 1 0.0030
123 LACRIMATION INCREASED 90 0.0030
124 SUSPECTED PRODUCT CONTAMINATION 3 0.0030
125 ACQUIRED OESOPHAGEAL WEB 1 0.0029
126 CORNEAL ABRASION 4 0.0029
127 CATARACT 173 0.0029
128 BREAST HYPERPLASIA 1 0.0028
129 EYELID OEDEMA 33 0.0028
130 EYE INFECTION 32 0.0028
131 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
132 LARYNGEAL DISORDER 2 0.0028
133 INFUSION SITE MASS 3 0.0028
134 INSTILLATION SITE REACTION 3 0.0028
135 HYPERPARATHYROIDISM PRIMARY 1 0.0027
136 PHOTOPHOBIA 51 0.0027
137 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
138 MACULAR DEGENERATION 32 0.0027
139 CORNEAL REFLEX DECREASED 1 0.0027
140 INSTILLATION SITE PRURITUS 1 0.0027
141 CONJUNCTIVAL DISORDER 1 0.0026
142 LIPID METABOLISM DISORDER 1 0.0026
143 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
144 FAECAL CALPROTECTIN ABNORMAL 1 0.0024
145 CORNEAL DYSTROPHY 1 0.0024
146 ABDOMINAL CAVITY DRAINAGE 1 0.0024
147 VITREOUS FLOATERS 23 0.0023
148 DACRYOSTENOSIS ACQUIRED 3 0.0023
149 BILIARY OBSTRUCTION 3 0.0023
150 PRODUCT USE COMPLAINT 36 0.0023
151 INFUSION SITE DISCOLOURATION 2 0.0023
152 EYELID INFECTION 1 0.0023
153 ALLERGY TO ARTHROPOD STING 1 0.0022
154 INFUSION SITE RASH 3 0.0022
155 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
156 ANGIOSARCOMA 1 0.0022
157 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 3 0.0021
158 EXCESSIVE EYE BLINKING 3 0.0020
159 BLEPHARITIS 8 0.0020
160 CORNEAL SCAR 1 0.0020
161 EYE INJURY 6 0.0020
162 DIABETIC RETINAL OEDEMA 1 0.0020
163 CATARACT OPERATION COMPLICATION 1 0.0020
164 ACCIDENT AT HOME 1 0.0019
165 EYE ALLERGY 3 0.0019
166 INFUSION SITE DISCOMFORT 2 0.0019
167 INTRAOCULAR PRESSURE DECREASED 1 0.0019
168 EYE CONTUSION 4 0.0019
169 VISION BLURRED 256 0.0019
170 IRIS DISORDER 1 0.0019
171 MILK ALLERGY 1 0.0018
172 ECZEMA EYELIDS 1 0.0018
173 EYE SWELLING 65 0.0017
174 TREATMENT DELAYED 3 0.0017
175 EYE DISORDER 56 0.0017
176 EYE BURNS 1 0.0017
177 INSTILLATION SITE IRRITATION 2 0.0017
178 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
179 PRODUCT CONTAMINATION MICROBIAL 2 0.0017
180 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
181 MEAN PLATELET VOLUME INCREASED 1 0.0017
182 EYELID SKIN DRYNESS 2 0.0016
183 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
184 RETINAL TEAR 4 0.0016
185 LOWER EXTREMITY MASS 1 0.0016
186 ARTHRITIS REACTIVE 1 0.0016
187 SWELLING OF EYELID 10 0.0016
188 INFUSION SITE PRURITUS 5 0.0016
189 CHALAZION 1 0.0016
190 MITRAL VALVE CALCIFICATION 1 0.0016
191 STOMA SITE INFECTION 2 0.0015
192 EXPIRED PRODUCT ADMINISTERED 51 0.0015
193 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
194 HERPES OPHTHALMIC 2 0.0015
195 ACROCHORDON 2 0.0015
196 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
197 BRONCHITIS VIRAL 1 0.0015
198 MACULAR FIBROSIS 1 0.0015
199 SKIN WRINKLING 4 0.0015
200 GENITAL SWELLING 1 0.0014
201 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
202 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
203 PERIORBITAL SWELLING 8 0.0014
204 FACIAL DISCOMFORT 1 0.0014
205 EYELID PTOSIS 14 0.0014
206 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
207 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
208 PRODUCT LOT NUMBER ISSUE 3 0.0014
209 CONJUNCTIVITIS ALLERGIC 2 0.0013
210 CORNEAL DEPOSITS 1 0.0013
211 PRODUCT LABEL ISSUE 9 0.0013
212 BRONCHITIS BACTERIAL 1 0.0013
213 ASTIGMATISM 2 0.0013
214 CHROMATOPSIA 1 0.0013
215 AGE-RELATED MACULAR DEGENERATION 2 0.0013
216 KERATITIS 4 0.0013
217 PRODUCT DELIVERY MECHANISM ISSUE 7 0.0013
218 GASTROINTESTINAL SURGERY 1 0.0013
219 EYELID DISORDER 3 0.0013
220 GLAUCOMA 25 0.0013
221 EYELID FUNCTION DISORDER 1 0.0013
222 GROWTH OF EYELASHES 1 0.0013
223 NIGHT BLINDNESS 2 0.0012
224 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
225 FEAR OF FALLING 1 0.0012
226 DYSCHROMATOPSIA 1 0.0012
227 PRODUCT PACKAGING ISSUE 11 0.0012
228 EYE INFLAMMATION 11 0.0012
229 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
230 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
231 ANIMAL BITE 3 0.0011
232 LIQUID PRODUCT PHYSICAL ISSUE 8 0.0011
233 ARNOLD-CHIARI MALFORMATION 1 0.0010
234 RETINAL OEDEMA 2 0.0010
235 CANCER SURGERY 1 0.0010
236 COLON NEOPLASM 1 0.0010
237 BONE SWELLING 1 0.0010
238 NEUROENDOCRINE CARCINOMA OF THE SKIN 1 0.0010
239 DUST ALLERGY 1 0.0010
240 DEVICE RELATED THROMBOSIS 1 0.0010
241 CATARACT OPERATION 6 0.0010
242 HEMIANOPIA 1 0.0010
243 EYE COLOUR CHANGE 1 0.0010
244 CAROTID ARTERIOSCLEROSIS 1 0.0010
245 BLINDNESS TRANSIENT 7 0.0009
246 INFUSION SITE BRUISING 2 0.0009
247 INFUSION SITE HAEMORRHAGE 3 0.0009
248 ESSENTIAL TREMOR 1 0.0009
249 MULTIPLE ALLERGIES 7 0.0009
250 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
251 HAEMOGLOBIN INCREASED 4 0.0009
252 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
253 READING DISORDER 2 0.0009
254 INTRAOCULAR PRESSURE INCREASED 11 0.0009
255 INGROWING NAIL 2 0.0008
256 MYOPIA 2 0.0008
257 COLON OPERATION 1 0.0008
258 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
259 EYE OEDEMA 2 0.0008
260 INFUSION SITE SWELLING 5 0.0008
261 PHOTOPSIA 5 0.0008
262 LEFT ATRIAL DILATATION 1 0.0008
263 HEPATIC INFECTION 1 0.0008
264 BLINDNESS UNILATERAL 11 0.0008
265 INFUSION SITE IRRITATION 1 0.0008
266 MADAROSIS 9 0.0008
267 PERIORBITAL OEDEMA 4 0.0008
268 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
269 PRODUCT FORMULATION ISSUE 5 0.0008
270 VISUAL ACUITY REDUCED 25 0.0008
271 BLOOD POTASSIUM ABNORMAL 2 0.0007
272 MACULAR HOLE 1 0.0007
273 STOMA SITE DISCHARGE 2 0.0007
274 ULCERATIVE KERATITIS 2 0.0007
275 IMMUNOGLOBULINS DECREASED 1 0.0007
276 DISCHARGE 1 0.0007
277 CHRONIC FATIGUE SYNDROME 1 0.0007
278 ELECTRIC SHOCK SENSATION 2 0.0007
279 NEUROENDOCRINE TUMOUR 1 0.0007
280 AUDITORY DISORDER 1 0.0007
281 OCULAR ICTERUS 3 0.0007
282 GASTROINTESTINAL WALL THICKENING 1 0.0007
283 MENTAL FATIGUE 1 0.0007
284 MOUTH INJURY 1 0.0007
285 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
286 RETINAL DETACHMENT 6 0.0007
287 ROSACEA 3 0.0006
288 INFUSION SITE EXTRAVASATION 4 0.0006
289 UMBILICAL HERNIA 3 0.0006
290 KERATOPATHY 1 0.0006
291 INTESTINAL OPERATION 1 0.0006
292 SKIN EROSION 2 0.0006
293 COLON CANCER METASTATIC 1 0.0006
294 INCORRECT PRODUCT STORAGE 8 0.0006
295 DEAFNESS NEUROSENSORY 2 0.0006
296 MEDICAL PROCEDURE 1 0.0006
297 ARTHROPOD STING 1 0.0006
298 EYE HAEMORRHAGE 8 0.0006
299 NEPHRITIS 2 0.0006
300 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
301 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
302 VISUAL IMPAIRMENT 72 0.0006
303 INCORRECT STORAGE OF DRUG 1 0.0006
304 SEASONAL ALLERGY 8 0.0006
305 BREAST CYST 1 0.0006
306 CONJUNCTIVAL HYPERAEMIA 2 0.0006
307 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
308 PRODUCT RESIDUE PRESENT 3 0.0006
309 DEVICE ALARM ISSUE 1 0.0006
310 PRODUCT ADMINISTRATION ERROR 11 0.0005
311 METAMORPHOPSIA 1 0.0005
312 DENTAL CARE 1 0.0005
313 BLINDNESS 22 0.0005
314 LYMPH NODE PAIN 1 0.0005
315 HYPERACUSIS 2 0.0005
316 PAROSMIA 4 0.0005
317 PARANASAL SINUS DISCOMFORT 2 0.0005
318 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
319 ARTERIAL DISORDER 1 0.0005
320 GINGIVAL DISORDER 2 0.0005
321 OESOPHAGEAL DISORDER 2 0.0005
322 HYPOGEUSIA 1 0.0005
323 JOINT NOISE 1 0.0005
324 SKIN ODOUR ABNORMAL 2 0.0005
325 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
326 LARGE INTESTINAL STENOSIS 1 0.0005
327 TRIGGER FINGER 2 0.0005
328 DIVERTICULAR PERFORATION 1 0.0005
329 CONJUNCTIVITIS 9 0.0005
330 SPINAL STENOSIS 2 0.0005
331 CHEST INJURY 1 0.0005
332 LIVEDO RETICULARIS 1 0.0005
333 BLEPHAROSPASM 3 0.0005
334 INFUSION SITE ERYTHEMA 4 0.0005
335 EAR SWELLING 1 0.0005
336 PRODUCT DISPENSING ISSUE 2 0.0005
337 HYPERPHOSPHATAEMIA 1 0.0005
338 GASTRIC BYPASS 1 0.0005
339 TONGUE DISCOLOURATION 2 0.0005
340 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
341 DISABILITY 9 0.0005
342 ENDOMETRIAL CANCER 1 0.0005
343 DANDRUFF 1 0.0005
344 FACIAL PAIN 4 0.0004
345 APPLICATION SITE URTICARIA 1 0.0004
346 FEAR OF DEATH 1 0.0004
347 CHRONIC GASTRITIS 1 0.0004
348 BLOOD LOSS ANAEMIA 1 0.0004
349 HAEMATOCRIT INCREASED 1 0.0004
350 DERMATITIS CONTACT 5 0.0004
351 EYE MOVEMENT DISORDER 3 0.0004
352 BRAIN OPERATION 1 0.0004
353 CYTOMEGALOVIRUS COLITIS 1 0.0004
354 ARTHRITIS 34 0.0004
355 DIPLOPIA 11 0.0004
356 THERMAL BURN 3 0.0004
357 LIMB OPERATION 2 0.0004
358 THERAPEUTIC RESPONSE DECREASED 25 0.0004
359 ACCIDENTAL OVERDOSE 15 0.0004
360 BRONCHITIS CHRONIC 1 0.0004
361 EXPIRED DRUG ADMINISTERED 2 0.0004
362 DEVICE INFUSION ISSUE 1 0.0004
363 CANCER PAIN 1 0.0004
364 MEAN CELL VOLUME INCREASED 1 0.0004
365 PELVIC FRACTURE 3 0.0004
366 HERNIA REPAIR 1 0.0004
367 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
368 TOOTH INFECTION 5 0.0004
369 NASAL DISCOMFORT 3 0.0004
370 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
371 FOOD POISONING 2 0.0004
372 ABDOMINAL MASS 1 0.0004
373 BREAST SWELLING 1 0.0004
374 SINUS CONGESTION 5 0.0004
375 LIP BLISTER 1 0.0004
376 BLOOD PHOSPHORUS INCREASED 1 0.0004
377 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
378 DIVERTICULITIS 10 0.0004
379 SKIN HYPERPIGMENTATION 3 0.0003
380 LIP PAIN 1 0.0003
381 HYPERTONIC BLADDER 1 0.0003
382 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
383 DYSPNOEA AT REST 1 0.0003
384 PRODUCT LABEL CONFUSION 2 0.0003
385 HYPERTRIGLYCERIDAEMIA 2 0.0003
386 SPINAL OSTEOARTHRITIS 3 0.0003
387 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
388 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
389 SINUS HEADACHE 2 0.0003
390 WRONG DRUG ADMINISTERED 3 0.0003
391 ODYNOPHAGIA 2 0.0003
392 INFUSION SITE REACTION 1 0.0003
393 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
394 CRANIOCEREBRAL INJURY 1 0.0003
395 IRITIS 1 0.0003
396 INGUINAL HERNIA 2 0.0003
397 BURNING SENSATION 23 0.0003
398 MENISCUS INJURY 2 0.0003
399 SKIN CANCER 7 0.0003
400 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
401 DIASTOLIC DYSFUNCTION 1 0.0003
402 PRODUCT DISPENSING ERROR 7 0.0003
403 THERAPY PARTIAL RESPONDER 5 0.0003
404 PRODUCT STORAGE ERROR 28 0.0003
405 EXPOSURE TO TOXIC AGENT 1 0.0003
406 LYMPHOCYTE COUNT INCREASED 1 0.0003
407 BREAST ENLARGEMENT 1 0.0003
408 HYPOGAMMAGLOBULINAEMIA 2 0.0003
409 SINUS DISORDER 6 0.0003
410 LYME DISEASE 1 0.0003
411 WRONG PRODUCT ADMINISTERED 2 0.0003
412 THROAT TIGHTNESS 8 0.0003
413 HEPATIC CYST 1 0.0003
414 EAR DISCOMFORT 3 0.0003
415 SCAR 5 0.0003
416 POOR VENOUS ACCESS 3 0.0003
417 CERVICAL VERTEBRAL FRACTURE 1 0.0003
418 LARGE INTESTINE POLYP 2 0.0003
419 MICTURITION DISORDER 1 0.0003
420 APHONIA 4 0.0003
421 CARPAL TUNNEL SYNDROME 4 0.0003
422 MACULOPATHY 1 0.0003
423 TONGUE DISORDER 2 0.0003
424 DEVICE KINK 1 0.0003
425 FOOD INTOLERANCE 1 0.0003
426 SNEEZING 6 0.0003
427 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
428 CHRONIC SINUSITIS 1 0.0003
429 IMPAIRED DRIVING ABILITY 3 0.0003
430 CONCUSSION 2 0.0003
431 BASAL CELL CARCINOMA 4 0.0003
432 CERVIX CARCINOMA 1 0.0003
433 DYSGEUSIA 19 0.0003
434 PULMONARY HAEMORRHAGE 2 0.0003
435 NAIL DISCOLOURATION 1 0.0003
436 PNEUMOTHORAX 4 0.0003
437 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
438 FRUSTRATION TOLERANCE DECREASED 2 0.0002
439 SWELLING FACE 16 0.0002
440 HYPERAESTHESIA 2 0.0002
441 RIB FRACTURE 5 0.0002
442 LEG AMPUTATION 1 0.0002
443 PHOTOSENSITIVITY REACTION 4 0.0002
444 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 49 0.0002
445 URINARY RETENTION 8 0.0002
446 SECRETION DISCHARGE 3 0.0002
447 SENSATION OF FOREIGN BODY 2 0.0002
448 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
449 MYDRIASIS 3 0.0002
450 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
451 INFUSION SITE PAIN 3 0.0002
452 SKIN SWELLING 2 0.0002
453 DEVICE USE ISSUE 4 0.0002
454 NAIL DISORDER 2 0.0002
455 MELANOCYTIC NAEVUS 1 0.0002
456 GRIP STRENGTH DECREASED 2 0.0002
457 PRODUCT COMMUNICATION ISSUE 2 0.0002
458 HEAD DISCOMFORT 4 0.0002
459 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
460 OROPHARYNGEAL DISCOMFORT 2 0.0002
461 HEAD INJURY 7 0.0002
462 UVEITIS 3 0.0002
463 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
464 LUMBAR VERTEBRAL FRACTURE 1 0.0002
465 NEPHROGENIC ANAEMIA 1 0.0002
466 SPINAL DISORDER 2 0.0002
467 FOOT FRACTURE 4 0.0002
468 ENDOMETRIOSIS 1 0.0002
469 RECALLED PRODUCT ADMINISTERED 2 0.0002
470 DRY MOUTH 17 0.0002
471 HYPOACUSIS 9 0.0002
472 POST PROCEDURAL COMPLICATION 4 0.0002
473 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
474 HYPERCHOLESTEROLAEMIA 2 0.0002
475 FINGER DEFORMITY 1 0.0002
476 VITAMIN D DEFICIENCY 2 0.0002
477 PHARYNGEAL SWELLING 2 0.0002
478 HYPERVOLAEMIA 1 0.0002
479 LIGAMENT SPRAIN 2 0.0002
480 FOOT OPERATION 1 0.0002
481 DIABETIC NEUROPATHY 1 0.0002
482 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
483 BLADDER DISORDER 2 0.0002
484 ABDOMINAL TENDERNESS 1 0.0002
485 RHINORRHOEA 13 0.0002
486 EPISTAXIS 15 0.0002
487 SPINAL FRACTURE 4 0.0002
488 DRUG TOLERANCE 1 0.0002
489 INSURANCE ISSUE 3 0.0002
490 THERAPY INTERRUPTED 14 0.0002
491 LYMPHOMA 3 0.0002
492 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
493 TENDERNESS 2 0.0002
494 PETECHIAE 2 0.0002
495 BRAIN FOG 3 0.0002
496 DEAFNESS 5 0.0002
497 TRANSFUSION 2 0.0002
498 GASTRITIS 5 0.0002
499 SCRATCH 2 0.0002
500 FULL BLOOD COUNT ABNORMAL 2 0.0002
501 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
502 SURGERY 11 0.0002
503 BODY HEIGHT DECREASED 2 0.0002
504 BRUXISM 1 0.0002
505 GINGIVITIS 1 0.0002
506 PRURITUS GENERALISED 4 0.0002
507 HIP SURGERY 1 0.0002
508 LIMB INJURY 5 0.0002
509 SKIN LACERATION 2 0.0002
510 HYPERSENSITIVITY 34 0.0002
511 FAECALOMA 1 0.0002
512 DEAFNESS UNILATERAL 1 0.0002
513 GASTRIC ULCER HAEMORRHAGE 1 0.0002
514 ERYTHEMA 37 0.0002
515 SKIN INFECTION 2 0.0002
516 SCAB 2 0.0002
517 MUSCULOSKELETAL DISCOMFORT 3 0.0002
518 CORONARY ARTERY BYPASS 1 0.0002
519 HERPES VIRUS INFECTION 1 0.0002
520 LABORATORY TEST ABNORMAL 5 0.0002
521 PRODUCT DOSE OMISSION 11 0.0002
522 THIRST 3 0.0002
523 ACCIDENT 2 0.0002
524 MUSCLE RIGIDITY 2 0.0002
525 HEARING IMPAIRED 1 0.0002
526 ENDOPHTHALMITIS 1 0.0002
527 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
528 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
529 DRUG INEFFECTIVE 214 0.0002
530 INJECTION SITE EXTRAVASATION 2 0.0002
531 GENERALISED OEDEMA 2 0.0002
532 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
533 INJECTION SITE DISCOLOURATION 2 0.0002
534 BLOOD SODIUM DECREASED 3 0.0002
535 LOWER LIMB FRACTURE 3 0.0002
536 SINUSITIS 16 0.0002
537 PRODUCT QUALITY ISSUE 21 0.0002
538 HIATUS HERNIA 2 0.0002
539 EAR PAIN 3 0.0002
540 HERPES SIMPLEX 1 0.0002
541 DYSGRAPHIA 1 0.0002
542 IMMUNE SYSTEM DISORDER 2 0.0002
543 SARS-COV-2 TEST POSITIVE 2 0.0002
544 CORONAVIRUS INFECTION 1 0.0002
545 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
546 PRODUCT TASTE ABNORMAL 2 0.0001
547 ABNORMAL LOSS OF WEIGHT 1 0.0001
548 MIGRAINE 14 0.0001
549 GASTRIC DISORDER 5 0.0001
550 MASS 2 0.0001
551 HAND FRACTURE 1 0.0001
552 BRONCHOSPASM 2 0.0001
553 IRRITABLE BOWEL SYNDROME 3 0.0001
554 OFF LABEL USE 122 0.0001
555 BALANCE DISORDER 12 0.0001
556 HEADACHE 87 0.0001
557 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
558 CHEST DISCOMFORT 14 0.0001
559 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
560 APPLICATION SITE PAIN 3 0.0001
561 PRODUCT DOSE OMISSION ISSUE 40 0.0001
562 DEVICE DIFFICULT TO USE 9 0.0001
563 ARTHROPOD BITE 1 0.0001
564 DRY SKIN 18 0.0001
565 FEELING DRUNK 1 0.0001
566 PULMONARY MASS 2 0.0001
567 COLON CANCER 2 0.0001
568 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
569 THROAT IRRITATION 6 0.0001
570 BREAST TENDERNESS 1 0.0001
571 UNEVALUABLE EVENT 10 0.0001
572 OSTEOPENIA 2 0.0001
573 VERTIGO 8 0.0001
574 HIP ARTHROPLASTY 2 0.0001
575 SKIN DISCOLOURATION 6 0.0001
576 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
577 THYROID DISORDER 2 0.0001
578 OROPHARYNGEAL PAIN 12 0.0001
579 FOOD ALLERGY 1 0.0001
580 ATRIOVENTRICULAR BLOCK 1 0.0001
581 LIMB DISCOMFORT 4 0.0001
582 MUSCULOSKELETAL CHEST PAIN 2 0.0001
583 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
584 RASH PRURITIC 7 0.0001
585 HYPOALBUMINAEMIA 1 0.0001
586 SWOLLEN TONGUE 4 0.0001
587 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
588 ILLNESS 13 0.0001
589 NEUROPATHY PERIPHERAL 12 0.0001
590 RESPIRATORY TRACT CONGESTION 2 0.0001
591 MOVEMENT DISORDER 4 0.0001
592 DECUBITUS ULCER 1 0.0001
593 BRONCHITIS 9 0.0001
594 ESCHERICHIA INFECTION 1 0.0001
595 HAIR DISORDER 1 0.0001
596 MUSCLE INJURY 1 0.0001
597 BREAST CANCER STAGE II 1 0.0001
598 GAIT INABILITY 4 0.0001
599 DYSPHONIA 7 0.0001
600 PRODUCT COMPLAINT 3 0.0001
601 BLOOD PRESSURE INCREASED 18 0.0001
602 COUGH 33 0.0001
603 CARDIAC OPERATION 1 0.0001
604 EXPOSURE VIA SKIN CONTACT 3 0.0001
605 MUSCLE STRAIN 1 0.0001
606 HYSTERECTOMY 1 0.0001
607 NERVOUSNESS 6 0.0001
608 DISCOMFORT 7 0.0001
609 PRURITUS 44 0.0001
610 HEART RATE DECREASED 4 0.0001
611 INCORRECT DOSE ADMINISTERED 26 0.0001
612 IMMUNOSUPPRESSION 1 0.0001
613 EAR INFECTION 3 0.0001
614 GALLBLADDER DISORDER 2 0.0001
615 GASTROINTESTINAL DISORDER 10 0.0001
616 GASTROINTESTINAL INFECTION 1 0.0001
617 THERAPY NON-RESPONDER 5 0.0001
618 HEAVY MENSTRUAL BLEEDING 1 0.0001
619 GASTROENTERITIS VIRAL 2 0.0001
620 TOOTHACHE 2 0.0001
621 HIDRADENITIS 1 0.0001
622 EXOSTOSIS 1 0.0001
623 SKIN LESION 3 0.0001
624 NERVE COMPRESSION 1 0.0001
625 THINKING ABNORMAL 2 0.0001
626 BACTERIAL INFECTION 2 0.0001
627 NEPHROPATHY 1 0.0001
628 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
629 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
630 LACERATION 1 0.0001
631 ARTERIOSCLEROSIS 1 0.0001
632 URINARY TRACT INFECTION 18 0.0001
633 INTENTIONAL DOSE OMISSION 3 0.0001
634 MUSCULOSKELETAL DISORDER 2 0.0001
635 RED BLOOD CELL COUNT DECREASED 3 0.0001
636 RASH ERYTHEMATOUS 5 0.0001
637 PULMONARY FIBROSIS 2 0.0001
638 CONTUSION 10 0.0001
639 ATELECTASIS 1 0.0001
640 HERNIA 2 0.0001
641 ERUCTATION 2 0.0001
642 DIZZINESS POSTURAL 1 0.0001
643 AUTOIMMUNE DISORDER 1 0.0001
644 HAEMORRHOIDS 2 0.0001
645 ORAL HERPES 2 0.0001
646 SKIN FISSURES 2 0.0001
647 KNEE OPERATION 1 0.0001
648 BODY TEMPERATURE DECREASED 1 0.0001
649 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
650 BLOOD PRESSURE ABNORMAL 2 0.0001
651 PRESCRIBED UNDERDOSE 2 0.0001
652 FULL BLOOD COUNT DECREASED 2 0.0001
653 TASTE DISORDER 2 0.0001
654 DRY THROAT 1 0.0001
655 EUPHORIC MOOD 1 0.0001
656 PERIPHERAL SWELLING 15 0.0001
657 COVID-19 17 0.0001
658 MUSCULAR WEAKNESS 11 0.0001
659 FALL 32 0.0001
660 POLLAKIURIA 4 0.0001
661 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
662 SPEECH DISORDER 5 0.0001
663 KNEE ARTHROPLASTY 2 0.0001
664 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
665 SKIN EXFOLIATION 8 0.0001
666 JOINT DISLOCATION 1 0.0001
667 OSTEOARTHRITIS 4 0.0001
668 DIZZINESS 47 0.0001
669 BREAST PAIN 1 0.0001
670 HIP FRACTURE 3 0.0001
671 POOR QUALITY SLEEP 2 0.0001
672 HALLUCINATION 7 0.0001
673 DECREASED ACTIVITY 1 0.0001
674 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
675 OEDEMA 5 0.0001
676 CHRONIC KIDNEY DISEASE 7 0.0001
677 BIPOLAR DISORDER 1 0.0001
678 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
679 IMPAIRED HEALING 3 0.0001
680 ASPIRATION 1 0.0001
681 BLOOD GLUCOSE FLUCTUATION 1 0.0001
682 GASTROINTESTINAL PAIN 1 0.0001
683 MELAENA 2 0.0001
684 PRODUCT USE ISSUE 17 0.0001
685 FOOT DEFORMITY 1 0.0001
686 FUNGAL INFECTION 3 0.0001
687 TOOTH DISORDER 2 0.0001
688 NECK PAIN 5 0.0001
689 RASH PAPULAR 2 0.0001
690 BLOOD CALCIUM DECREASED 1 0.0001
691 MITRAL VALVE INCOMPETENCE 1 0.0001
692 MYOCARDIAL ISCHAEMIA 1 0.0001
693 PRODUCT AVAILABILITY ISSUE 2 0.0001
694 INTERNAL HAEMORRHAGE 1 0.0001
695 FATIGUE 68 0.0001
696 SKIN IRRITATION 4 0.0001
697 NEPHROLITHIASIS 4 0.0001
698 TINNITUS 4 0.0001
699 HERPES ZOSTER 5 0.0001
700 THROMBOSIS 7 0.0001
701 NEOPLASM 1 0.0001
702 LETHARGY 5 0.0001
703 HYPOAESTHESIA 13 0.0001
704 MUSCLE TWITCHING 2 0.0001
705 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
706 RASH MACULAR 3 0.0001
707 BLOOD CHOLESTEROL INCREASED 4 0.0001
708 PAIN IN EXTREMITY 25 0.0001
709 COVID-19 PNEUMONIA 1 0.0001
710 TREMOR 14 0.0001
711 SKIN BURNING SENSATION 6 0.0001
712 BLOOD PRESSURE FLUCTUATION 2 0.0001
713 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
714 IRRITABILITY 5 0.0001
715 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
716 LOCALISED INFECTION 2 0.0001
717 ADRENAL INSUFFICIENCY 1 0.0001
718 NEURALGIA 2 0.0001
719 UNDERDOSE 6 0.0001
720 CYTOPENIA 1 0.0001
721 NASOPHARYNGITIS 15 0.0001
722 INFLUENZA 9 0.0001
723 CYST 1 0.0001
724 AGEUSIA 2 0.0001
725 INTENTIONAL PRODUCT MISUSE 7 0.0001
726 DYSPNOEA EXERTIONAL 3 0.0001
727 FLUSHING 8 0.0001
728 FLUID RETENTION 4 0.0001
729 HOSPITALISATION 12 0.0001
730 DIARRHOEA 50 0.0001
731 SKIN ULCER 2 0.0001
732 CHILLS 9 0.0001
733 ECZEMA 4 0.0001
734 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
735 ADVERSE EVENT 7 0.0001
736 ADVERSE REACTION 1 0.0001
737 INSOMNIA 20 0.0001
738 SOMNOLENCE 15 0.0001
739 FEAR 2 0.0001
740 MALAISE 32 0.0001
741 CORONARY ARTERY OCCLUSION 1 0.0001
742 ABDOMINAL PAIN UPPER 15 0.0001
743 ABNORMAL DREAMS 2 0.0001
744 PROCEDURAL PAIN 2 0.0001
745 DEMENTIA 2 0.0001
746 ALOPECIA 14 0.0001
747 BLISTER 4 0.0001
748 OXYGEN SATURATION DECREASED 4 0.0001
749 BLOOD TEST ABNORMAL 1 0.0001
750 ASTHMA 8 0.0001
751 LYMPHOPENIA 1 0.0001
752 PAIN IN JAW 2 0.0001
753 IMPAIRED QUALITY OF LIFE 1 0.0001
754 SEIZURE 8 0.0001
755 HYPERTHYROIDISM 1 0.0001
756 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
757 PALPITATIONS 8 0.0001
758 BONE PAIN 4 0.0001
759 NASAL CONGESTION 4 0.0001
760 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
761 WHEEZING 4 0.0001
762 IMMUNODEFICIENCY 1 0.0001
763 ABDOMINAL DISTENSION 7 0.0001
764 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
765 BLOOD POTASSIUM DECREASED 2 0.0001
766 HYPOAESTHESIA ORAL 1 0.0001
767 CORONARY ARTERY DISEASE 2 0.0001
768 ACNE 5 0.0001
769 CEREBROVASCULAR ACCIDENT 11 0.0001
770 NAUSEA 51 0.0001
771 DELUSION 1 0.0001
772 LUNG INFECTION 1 0.0001
773 COGNITIVE DISORDER 3 0.0001
774 SWELLING 6 0.0001
775 NERVOUS SYSTEM DISORDER 2 0.0001
776 ASTHENIA 24 0.0001
777 CYANOSIS 1 0.0001
778 PAIN 39 0.0001
779 PRODUCTIVE COUGH 3 0.0001
780 CYSTITIS 2 0.0001
781 HYPOTHYROIDISM 2 0.0001
782 BLOOD GLUCOSE DECREASED 3 0.0001
783 INTERSTITIAL LUNG DISEASE 3 0.0001
784 BACK DISORDER 1 0.0001
785 AMNESIA 4 0.0001
786 LUNG DISORDER 3 0.0001
787 HEART RATE INCREASED 6 0.0001
788 ARTHRALGIA 25 0.0001
789 VIRAL INFECTION 2 0.0001
790 LIP SWELLING 2 0.0001
791 DEHYDRATION 8 0.0001
792 NEOPLASM MALIGNANT 4 0.0001
793 RASH 26 0.0001
794 CELLULITIS 3 0.0001
795 FACE OEDEMA 1 0.0001
796 HEMIPARESIS 1 0.0001
797 MYALGIA 10 0.0001
798 HEPATIC ENZYME INCREASED 4 0.0001
799 INFLAMMATION 3 0.0001
800 JOINT SWELLING 7 0.0001
801 NIGHTMARE 2 0.0001
802 OEDEMA PERIPHERAL 7 0.0001
803 LOCAL SWELLING 1 0.0001
804 MUSCULOSKELETAL STIFFNESS 5 0.0001
805 SLEEP DISORDER 4 0.0001
806 HYPERTENSION 12 0.0001
807 LYMPHOCYTE COUNT DECREASED 1 0.0001
808 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
809 LYMPHADENOPATHY 2 0.0001
810 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
811 TACHYCARDIA 5 0.0001
812 DEVICE ISSUE 5 0.0001
813 GOUT 1 0.0001
814 PNEUMONIA 18 0.0001
815 CONSTIPATION 12 0.0001
816 BONE DISORDER 1 0.0001
817 DYSURIA 2 0.0001
818 BLOOD GLUCOSE ABNORMAL 1 0.0001
819 ARTHROPATHY 3 0.0001
820 WEIGHT DECREASED 15 0.0001
821 CARDIAC DISORDER 5 0.0001
822 HOT FLUSH 4 0.0001
823 FLATULENCE 3 0.0001
824 HYPOCALCAEMIA 1 0.0001
825 FRACTURE 1 0.0001
826 COLITIS 2 0.0001
827 ANXIETY 15 0.0001
828 BLOOD URINE PRESENT 1 0.0001
829 CONDITION AGGRAVATED 16 0.0001
830 DRUG PRESCRIBING ERROR 1 0.0001
831 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
832 BACK PAIN 12 0.0001
833 DYSTONIA 1 0.0001
834 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
835 KIDNEY INFECTION 1 0.0001
836 MEMORY IMPAIRMENT 7 0.0001
837 MENORRHAGIA 1 0.0001
838 HAEMATOCRIT DECREASED 1 0.0001
839 HYPOTENSION 10 0.0000
840 CARDIAC FAILURE 4 0.0000
841 STOMATITIS 3 0.0000
842 DYSKINESIA 2 0.0000
843 INJURY ASSOCIATED WITH DEVICE 1 0.0000
844 BODY TEMPERATURE INCREASED 1 0.0000
845 OSTEOPOROSIS 2 0.0000
846 DRUG DOSE OMISSION 8 0.0000
847 INFECTION 7 0.0000
848 ROAD TRAFFIC ACCIDENT 2 0.0000
849 DERMATITIS 1 0.0000
850 ABDOMINAL DISCOMFORT 8 0.0000
851 MOUTH ULCERATION 1 0.0000
852 HALLUCINATION, VISUAL 1 0.0000
853 JOINT INJURY 1 0.0000
854 DEVICE LEAKAGE 2 0.0000
855 FAECES DISCOLOURED 1 0.0000
856 DEVICE DISLOCATION 2 0.0000
857 DYSPNOEA 26 0.0000
858 FEELING ABNORMAL 11 0.0000
859 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
860 INFUSION RELATED REACTION 3 0.0000
861 BLOOD PRESSURE DECREASED 3 0.0000
862 GLOSSODYNIA 1 0.0000
863 HEART RATE IRREGULAR 1 0.0000
864 RHEUMATOID ARTHRITIS 5 0.0000
865 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
866 MUSCLE SPASMS 8 0.0000
867 HYPOKALAEMIA 2 0.0000
868 CONFUSIONAL STATE 7 0.0000
869 RENAL DISORDER 2 0.0000
870 VOMITING 20 0.0000
871 DYSPHAGIA 4 0.0000
872 PULMONARY EMBOLISM 4 0.0000
873 DISEASE RECURRENCE 2 0.0000
874 COMA 2 0.0000
875 GAIT DISTURBANCE 8 0.0000
876 URTICARIA 7 0.0000
877 FIBROMYALGIA 1 0.0000
878 ATRIAL FIBRILLATION 4 0.0000
879 INJECTION SITE URTICARIA 1 0.0000
880 ABASIA 1 0.0000
881 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
882 GASTRIC CANCER 1 0.0000
883 DIABETES MELLITUS 3 0.0000
884 HYPOPHAGIA 1 0.0000
885 THERAPY CESSATION 2 0.0000
886 HAEMOGLOBIN DECREASED 4 0.0000
887 HAEMATOMA 1 0.0000
888 APPLICATION SITE ERYTHEMA 1 0.0000
889 JOINT STIFFNESS 1 0.0000
890 INJECTION SITE BRUISING 3 0.0000
891 MENSTRUATION IRREGULAR 1 0.0000
892 DRUG EFFECT DECREASED 2 0.0000
893 FREQUENT BOWEL MOVEMENTS 1 0.0000
894 BLOOD BILIRUBIN INCREASED 1 0.0000
895 NEUTROPENIA 5 0.0000
896 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
897 INFLUENZA LIKE ILLNESS 3 0.0000
898 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
899 MENTAL STATUS CHANGES 1 0.0000
900 MEDICATION ERROR 2 0.0000
901 FEELING COLD 1 0.0000
902 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
903 SEPSIS 4 0.0000
904 HAEMOPTYSIS 1 0.0000
905 WEIGHT INCREASED 8 0.0000
906 HYPERSOMNIA 1 0.0000
907 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
908 NEEDLE ISSUE 1 0.0000
909 DYSSTASIA 1 0.0000
910 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
911 ASCITES 1 0.0000
912 ADVERSE DRUG REACTION 3 0.0000
913 NO ADVERSE EVENT 6 0.0000
914 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
915 ILL-DEFINED DISORDER 2 0.0000
916 EPILEPSY 1 0.0000
917 FEELING HOT 2 0.0000
918 INJECTION SITE RASH 1 0.0000
919 DRUG ADMINISTRATION ERROR 1 0.0000
920 EMOTIONAL DISORDER 1 0.0000
921 CHEST PAIN 6 0.0000
922 FEMUR FRACTURE 1 0.0000
923 INJECTION SITE ERYTHEMA 4 0.0000
924 DRUG-INDUCED LIVER INJURY 1 0.0000
925 PARAESTHESIA 5 0.0000
926 METABOLIC ACIDOSIS 1 0.0000
927 LOSS OF CONSCIOUSNESS 4 0.0000
928 HYPERHIDROSIS 4 0.0000
929 DEPRESSION 7 0.0000
930 BLOOD CREATININE INCREASED 2 0.0000
931 DYSPEPSIA 3 0.0000
932 DECREASED APPETITE 7 0.0000
933 ABDOMINAL PAIN 7 0.0000
934 INJECTION SITE PRURITUS 2 0.0000
935 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
936 INJECTION SITE REACTION 2 0.0000
937 PYREXIA 10 0.0000
938 DEVICE USE ERROR 1 0.0000
939 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
940 MOBILITY DECREASED 2 0.0000
941 DRUG EFFECT INCOMPLETE 1 0.0000
942 AGITATION 2 0.0000
943 DYSARTHRIA 1 0.0000
944 INJECTION SITE SWELLING 2 0.0000
945 DISEASE PROGRESSION 3 0.0000
946 INJECTION SITE HAEMORRHAGE 2 0.0000
947 PROSTATE CANCER 2 0.0000
948 EXTRA DOSE ADMINISTERED 1 0.0000
949 DEVICE BREAKAGE 1 0.0000
950 DEATH 21 0.0000
951 LUNG NEOPLASM MALIGNANT 1 0.0000
952 TREATMENT FAILURE 2 0.0000
953 RENAL IMPAIRMENT 2 0.0000
954 MENTAL DISORDER 1 0.0000
955 MYOCARDIAL INFARCTION 4 0.0000
956 RENAL FAILURE 3 0.0000
957 LIVER DISORDER 1 0.0000
958 COLITIS ULCERATIVE 1 0.0000
959 BREAST CANCER 2 0.0000
960 ARRHYTHMIA 1 0.0000
961 ANAEMIA 4 0.0000
962 MULTIPLE SCLEROSIS 1 0.0000
963 DRUG INTOLERANCE 2 0.0000
964 HYPOGLYCAEMIA 1 0.0000
965 LEUKOPENIA 1 0.0000
966 SYNCOPE 2 0.0000
967 AGGRESSION 1 0.0000
968 INJECTION SITE PAIN 6 0.0000
969 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
970 HAEMORRHAGE 2 0.0000
971 MUSCULOSKELETAL PAIN 1 0.0000
972 DEPRESSED MOOD 1 0.0000
973 BRADYCARDIA 1 0.0000
974 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
975 PLATELET COUNT DECREASED 2 0.0000
976 DISTURBANCE IN ATTENTION 1 0.0000
977 HAEMATOCHEZIA 1 0.0000
978 EMOTIONAL DISTRESS 2 0.0000
979 BLOOD GLUCOSE INCREASED 3 0.0000
980 FEBRILE NEUTROPENIA 1 0.0000
981 INJURY 1 0.0000
982 DRUG INTERACTION 2 0.0000
983 CARDIAC ARREST 1 0.0000